Dermatology.

The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol (1990) 3.32

Leg ulcers. J Am Acad Dermatol (1991) 2.74

Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol (2001) 2.33

Citation classics in clinical dermatologic journals. Citation analysis, biomedical journals, and landmark articles, 1945-1990. Arch Dermatol (1993) 2.08

Relief of uremic pruritus with ultraviolet phototherapy. N Engl J Med (1977) 2.06

Dermatology. JAMA (1997) 2.03

Use of short-course class 1 topical glucocorticoid under occlusion for the rapid control of erythrodermic psoriasis. Arch Dermatol (1994) 2.03

Treatment of tattoos by Q-switched ruby laser. A dose-response study. Arch Dermatol (1990) 2.01

Diagnostic accuracy and appropriateness of care for seborrheic keratoses. A pilot study of an approach to quality assurance for cutaneous surgery. JAMA (1991) 1.72

Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. J Infect Dis (1982) 1.72

Selective photothermolysis of cutaneous pigmentation by Q-switched Nd: YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol (1989) 1.60

Laser treatment of pigmented lesions--2000: how far have we gone? Arch Dermatol (2000) 1.54

Brief report: graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors. N Engl J Med (1993) 1.46

Failure of neutral-red photodynamic inactivation in recurrent herpes simplex virus infections. N Engl J Med (1975) 1.43

Transfusion-associated graft-vs-host disease in patients with malignancies. Report of two cases and review of the literature. Arch Dermatol (1990) 1.42

Top cited authors in dermatology: a citation study from 24 journals: 1982-1996. Arch Dermatol (1999) 1.42

Efficiency of opaque photoprotective agents in the visible light range. Arch Dermatol (1991) 1.41

Cutaneous effects and therapeutic uses of heat with emphasis on infrared radiation. J Am Acad Dermatol (1989) 1.41

Archives of Dermatology. Second century. Arch Dermatol (1984) 1.39

Minimizing the pain of local anaesthesia. Clin Exp Dermatol (1992) 1.39

Facial skin rejuvenation: laser resurfacing or chemical peel: choose your weapon. Dermatol Surg (2001) 1.39

Keloids and hypertrophic scars: review and treatment strategies. Semin Cutan Med Surg (1999) 1.37

Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program. JAMA (1976) 1.20

Necrobiosis lipoidica. J Am Acad Dermatol (1991) 1.16

Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir. Antimicrob Agents Chemother (1984) 1.12

The role of lasers and light sources in the treatment of leg veins. Dermatol Surg (1999) 1.11

Chronic localized herpes zoster in the acquired immunodeficiency syndrome. Arch Dermatol (1990) 1.10

Laser therapy. Basic concepts and nomenclature. J Am Acad Dermatol (1981) 1.10

Prevalence of skin disease in a cohort of shelter-based homeless men. J Am Acad Dermatol (1999) 1.10

Complications of cutaneous laser surgery. A survey. Arch Dermatol (1987) 1.06

Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo. Arch Dermatol (1966) 1.05

Scarring following Q-switched laser treatment of "double tattoos". Arch Dermatol (2000) 1.01

Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol (1996) 0.99

Lasers in dermatology. Arch Dermatol (1982) 0.99

Accessibility and reliability of cutaneous laser surgery information on the World Wide Web. J Am Acad Dermatol (2000) 0.98

Topical use of hydroquinone as a depigmenting agent. JAMA (1965) 0.94

Disseminated superficial actinic porokeratosis. Coexistence with other porokeratotic variants. Arch Dermatol (1986) 0.93

Release of prostaglandin D2 and histamine in a case of localized heat urticaria, and effect of treatments. Br J Dermatol (1986) 0.92

Classic and near-classic articles in the dermatologic literature. Arch Dermatol (1999) 0.91

Serum albumin. Differences in assay specificity. Nutr Clin Pract (1989) 0.91

Clinical features of pruritus among patients undergoing maintenance hemodialysis. Arch Dermatol (1982) 0.90

Birt-Hogg-Dube syndrome: treatment of cutaneous manifestations with laser skin resurfacing. Arch Dermatol (2001) 0.90

Vancomycin-induced linear IgA bullous dermatosis. Arch Dermatol (1988) 0.89

New approaches to the treatment of vascular lesions. Lasers Surg Med (2000) 0.89

A clinical and histologic prospective controlled comparative study of the picosecond titanium:sapphire (795 nm) laser versus the Q-switched alexandrite (752 nm) laser for removing tattoo pigment. J Am Acad Dermatol (1999) 0.89

Top-cited dermatology authors publishing in 5 "high-impact" general medical journals. Arch Dermatol (2000) 0.89

Cutting and grinding fluids and their effects on the skin. Am Ind Hyg Assoc J (1967) 0.89

Recent advances in dermatology. N Engl J Med (1992) 0.88

Bullae: a cutaneous sign of a variety of neurologic diseases. J Invest Dermatol (1973) 0.88

Basic laser principles. Dermatol Clin (1997) 0.88

Q-switched ruby laser irradiation of normal human skin. Histologic and ultrastructural findings. Arch Dermatol (1991) 0.87

Treatment of pityriasis rosea with UV radiation. Arch Dermatol (1983) 0.87

Cyclosporine inhibits basic fibroblast growth factor-driven proliferation of human endothelial cells and keratinocytes. Arch Dermatol (1989) 0.87

Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanism of action. Ann Intern Med (1979) 0.87

Melanosomes are a primary target of Q-switched ruby laser irradiation in guinea pig skin. J Invest Dermatol (1987) 0.86

Cutaneous polyarteritis nodosa associated with hepatitis B surface antigen. J Am Acad Dermatol (1986) 0.86

On beauty: evolution, psychosocial considerations, and surgical enhancement. Arch Dermatol (2001) 0.86

Fractional Laser treatment for pigmentation and texture improvement. Skin Therapy Lett (2006) 0.85

Laser therapy versus cryotherapy of lentigines: a comparative trial. J Am Acad Dermatol (1994) 0.85

Minimizing the pain of local anesthesia. Plast Reconstr Surg (1983) 0.85

Low-fluence carbon dioxide laser irradiation of lentigines. Arch Dermatol (1988) 0.83

Postrhinoplasty "red nose": differential diagnosis and treatment by laser. Plast Reconstr Surg (1981) 0.82

Sebaceous adenoma in a patient with acquired immunodeficiency syndrome. Arch Dermatol (1988) 0.82

The sign of Pyotr Vasilyewich Nikolsky. N Engl J Med (1970) 0.82

Pemphigus foliaceus induced by psoralen-UV-A. Arch Dermatol (1998) 0.81

Seborrhoeic dermatitis of the beard. Br J Dermatol (1972) 0.81

Low-intensity selective UV phototherapy. A clinical trial in outpatient therapy for psoriasis. Arch Dermatol (1983) 0.81

Pancytopenia induced by the interaction between methotrexate and trimethoprim-sulfamethoxazole. J Am Acad Dermatol (1987) 0.81

Diagnostic clues to dermatitis artefacta. Cutis (1999) 0.81

The use of lasers for decorative tattoo removal. Skin Therapy Lett (2006) 0.81

Interaction between cyclosporin and rifampicin. Lancet (1984) 0.81

Lichenoid dermatoses and related disorders. II. Lichen nitidus, lichen sclerosus et atrophicus, benign lichenoid keratoses, lichen aureus, pityriasis lichenoides, and keratosis lichenoides chronica. J Am Acad Dermatol (1990) 0.81

Laser skin resurfacing. Arch Dermatol (1996) 0.81

Evaluation of a silicone occlusive dressing after laser skin resurfacing. Arch Dermatol (2001) 0.81

New pigmented macule appearing 4 years after argon laser treatment of lentigo maligna. J Am Acad Dermatol (1986) 0.81

Treatment of acne scarring. Skin Therapy Lett (2006) 0.80

Autonomic neurodermatology (Part II): Disorders of sweating and flushing. Semin Neurol (1992) 0.80

Visible action spectrum for melanin-specific selective photothermolysis. Lasers Surg Med (1989) 0.79

Argon laser therapy of small cutaneous vascular lesions. Arch Dermatol (1982) 0.79

Combined methotrexate--ultraviolet B therapy in the treatment of psoriasis. J Am Acad Dermatol (1982) 0.79

Acral lentiginous melanoma. Ann Plast Surg (1980) 0.79

A clinical overview of hair removal using lasers and light sources. Dermatol Clin (1999) 0.79

The TORCH syndrome: a clinical review. J Am Acad Dermatol (1985) 0.79

Inhibition of cutaneous contact hypersensitivity in the mouse with systemic or topical spiperone: topical application of spiperone produces local immunosuppression without inducing systemic neuroleptic effects. J Invest Dermatol (1992) 0.78

Role of ultraviolet A in phototherapy for psoriasis. J Am Acad Dermatol (1984) 0.78

Dual publication and manipulation of the editorial process. Int J Dermatol (1990) 0.78

Dermatology. JAMA (1992) 0.78

Port-wine stains. Morphologic variations and developmental lesions. Arch Dermatol (1984) 0.77

Laser treatment of tattoos: a prospective, paired, comparison study of the Q-switched Nd:YAG (1064 nm), frequency-doubled Q-switched Nd:YAG (532 nm), and Q-switched ruby lasers. J Am Acad Dermatol (1997) 0.77

The use of lasers in the pediatric population. Skin Therapy Lett (2005) 0.77

Psoriasis treatment with suberythemogenic ultraviolet B radiation and a coal tar extract. J Am Acad Dermatol (1985) 0.77

Macromolecular metabolism in hyperplastic epidermal disease--a radio-autographic study. Br J Dermatol (1974) 0.77